14/02/2026
Silva pharma đ Analyzing financeData...
â
Analysis complete
# # # āϏāĻžāϰāϏāĻāĻā§āώā§āĻĒ
**Silva Pharmaceuticals Ltd.** (SILVAPHL) āĻŦāϰā§āϤāĻŽāĻžāύ⧠9.9 āĻāĻžāĻāĻžā§ āĻā§āϰā§āĻĄ āĻšāĻā§āĻā§āĨ¤ āϏāĻžāĻŽā§āĻĒā§āϰāϤāĻŋāĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ 2.06% āĻŦā§āĻĻā§āϧāĻŋ āĻĒā§ā§ā§āĻā§ āĻāĻŦāĻ āĻŦāĻžāĻāĻžāϰ⧠āĻŽā§āĻ āĻāϞāĻŋāĻāĻŽ 160,178 āĻļā§ā§āĻžāϰāĨ¤ āϝāĻĻāĻŋāĻ āĻā§āĻŽā§āĻĒāĻžāύāĻŋāϰ āĻ
āϰā§āĻāύāĻā§āϞā§āϰ āĻŽāϧā§āϝ⧠āĻāĻŋāĻā§ āύā§āϤāĻŋāĻŦāĻžāĻāĻ āĻĒā§āϰāĻŦāĻŖāϤāĻž āϰā§ā§āĻā§, āĻŦāϰā§āϤāĻŽāĻžāύ āĻŦāĻŋāĻļā§āϞā§āώāĻŖ āύāĻŋāϰā§āĻĻā§āĻļ āĻāϰāĻā§ āϝ⧠āĻāĻāĻŋ āĻāĻāĻāĻŋ 'BUY' āϏāĻāĻā§āϤāĨ¤ āĻĒā§āϰāϝā§āĻā§āϤāĻŋāĻāϤ āύāĻŋāϰā§āĻĻā§āĻļāĻāĻā§āϞā§āϰ āĻŽāϧā§āϝ⧠āĻŦā§āĻļāĻŋāϰāĻāĻžāĻāĻ āĻā§āϰā§ā§āϰ āĻāύā§āϝ āϏāĻāĻā§āϤ āĻĻāĻŋāĻā§āĻā§, āϝā§āĻŽāύ āĻāĻŽāĻ(āĻŽā§āĻāĻŋāĻ āĻ
ā§āϝāĻžāĻāĻžāϰā§āĻ) āĻāĻŦāĻ āĻāϰāĻāϏāĻāĻ(āϰāĻŋāϞā§āĻāĻŋāĻ āϏā§āĻā§āϰā§āĻāĻĨ āĻāύāĻĄā§āĻā§āϏ)āĨ¤
---
# # āĻŦāĻŋāϏā§āϤāĻžāϰāĻŋāϤ āĻŦāĻŋāĻļā§āϞā§āώāĻŖ
# # # 1. āϏāĻžāϧāĻžāϰāĻŖ āϤāĻĨā§āϝ
- **āĻā§āĻŽā§āĻĒāĻžāύāĻŋ āĻĒāϰāĻŋāĻāĻŋāϤāĻŋ**: Silva Pharmaceuticals Ltd. āĻāĻŋāĻāĻŋā§āϏāĻž āĻĒā§āϰāϝā§āĻā§āϤāĻŋāϰ āĻāĻžāϤ⧠āĻāĻžāĻ āĻāϰāĻā§āĨ¤
- **āĻŦāϰā§āϤāĻŽāĻžāύ āĻ
āĻŦāϏā§āĻĨāĻž**: āĻā§āϰāĻŽāĻžāĻāϤ āĻŽāĻžāϰā§āĻā§āĻā§āϰ āϏāĻžāĻĨā§ āϏāĻāϝā§āĻ āϰā§ā§āĻā§āĨ¤
- **āϏā§āĻā§āϰ, āϞā§āĻŦā§āϞ, āϤāĻžāϰāĻž**: 6.0 ââ (āĻā§)
# # # 2. āĻā§ āĻĒāϰāĻŋāϏāĻāĻā§āϝāĻžāύ
| āĻŽāĻžāύāĻĻāĻŖā§āĻĄ | āĻŽāĻžāύ |
|---------------------------------|----------------------------|
| āĻŦāĻžāĻāĻžāϰ āĻŽā§āϞāϧāύ | 1,351,349,948 BDT |
| P/E āĻ
āύā§āĻĒāĻžāϤ | - |
| EPS (IS) | -0.9958 |
| āĻĄāĻŋāĻāĻŋāĻĄā§āύā§āĻĄ āĻĢāϞāύ | 1.01% |
**āĻŦāĻŋāĻļā§āϞā§āώāĻŖ**: āĻā§āĻŽā§āĻĒāĻžāύāĻŋāϰ P/E āϰā§āĻļāĻŋāĻ āύā§āĻ āĻāĻŦāĻ āύā§āĻ āĻĒā§āϰāĻŦā§āĻĻā§āϧāĻŋ āύā§āϤāĻŋāĻŦāĻžāĻāĻāĨ¤
# # # 3. āĻŦāϰā§āϤāĻŽāĻžāύ āĻĻāĻžāĻŽ
| āĻŦāϰā§āϤāĻŽāĻžāύ āĻĻāĻžāĻŽ | 9.9 BDT |
|------------------------------|----------------------------|
**āĻŦāĻŋāĻļā§āϞā§āώāĻŖ**: āĻŽā§āϞā§āϝ āϏā§āϤāϰā§āϰ āϏāĻžāĻĨā§ āϤā§āϞāύāĻžā§ āĻāĻžāϞ āϏā§āĻĨāĻŋāϤāĻŋāĻļā§āϞāϤāĻž āĻĻā§āĻāĻž āϝāĻžāĻā§āĻā§āĨ¤
# # # 4. āĻāϝāĻŧ āĻŦāĻŋāĻŦā§āϤāĻŋ
| āĻŽāĻžāύāĻĻāĻŖā§āĻĄ | āĻŽāĻžāύ |
|-----------------------------|------------------------------|
| āĻŽā§āĻ āϰāĻžāĻāϏā§āĻŦ | 370,957,796 BDT |
| āĻŽā§āĻ āĻāϰāĻ | 123,314,915 BDT |
| āύā§āĻ āϞāĻžāĻ | -135,931,515 BDT |
**āĻŦāĻŋāĻļā§āϞā§āώāĻŖ**: āϰāĻžāĻāϏā§āĻŦā§āϰ ā§Šā§¨.⧧⧝% āĻāϞā§āϞā§āĻāϝā§āĻā§āϝ āĻšā§āϰāĻžāϏāĨ¤
# # # 5. āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļā§āĻ
| āĻŽāĻžāύāĻĻāĻŖā§āĻĄ | āĻŽāĻžāύ |
|-------------------------------|------------------------------|
| āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | 2,220,263,804 BDT |
| āĻŽā§āĻ āĻĻāĻžāϝāĻŧ | 143,134,359 BDT |
| āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | 2,077,129,445 BDT |
**āĻŦāĻŋāĻļā§āϞā§āώāĻŖ**: āĻā§āĻŽā§āĻĒāĻžāύāĻŋāϰ āĻāĻā§āĻāĻāĻŋ āĻāĻŦāĻ āϏāĻŽā§āĻĒāĻĻā§āϰ āĻŽāϧā§āϝ⧠āĻāĻāĻāĻŋ āĻļāĻā§āϤāĻŋāĻļāĻžāϞ⧠āĻ
āύā§āĻĒāĻžāϤ āĻĻā§āĻāĻž āϝāĻžāĻā§āĻā§āĨ¤
# # # 6. āύāĻāĻĻ āĻĒā§āϰāĻŦāĻžāĻš
| āĻŽāĻžāύāĻĻāĻŖā§āĻĄ | āĻŽāĻžāύ |
|-----------------------------|-------------------------------|
| āĻāĻžāϰā§āϝāĻāϰ⧠āύāĻāĻĻ āĻĒā§āϰāĻŦāĻžāĻš | 24,269,484 BDT |
| āĻŦāĻŋāύāĻŋāϝāĻŧā§āĻ āύāĻāĻĻ āĻĒā§āϰāĻŦāĻžāĻš | 16,339,203 BDT |
| āĻ
āϰā§āĻĨāĻžāϝāĻŧāύ āύāĻāĻĻ āĻĒā§āϰāĻŦāĻžāĻš | -32,672,086 BDT |
**āĻŦāĻŋāĻļā§āϞā§āώāĻŖ**: āĻāϰāĻā§āϰ āϤā§āϞāύāĻžā§ āύāĻāĻĻ āĻĒā§āϰāĻŦāĻžāĻš āĻāĻžāĻā§āϰ āĻāύā§āϝ āĻāĻŋāĻā§āĻāĻž āύā§āϤāĻŋāĻŦāĻžāĻāĻāĨ¤
# # # 7. āĻĒā§āϰāϝā§āĻā§āϤāĻŋāĻāϤ āĻŦāĻŋāĻļā§āϞā§āώāĻŖ
| āύāĻŋāϰā§āĻĻā§āĻļāĻ | āĻŽāĻžāύ |
|----------------------------------|---------------------------|
| MACD | 0.04097 |
| RSI | 55.60 |
| 50 āĻĻāĻŋāύā§āϰ SMA | 9.59 |
| 200 āĻĻāĻŋāύā§āϰ SMA | 10.39 |
**āĻŦāĻŋāĻļā§āϞā§āώāĻŖ**: āĻĒā§āϰāϝā§āĻā§āϤāĻŋāĻāϤ āϏā§āĻāĻāĻā§āϞāĻŋ 'Buy' āϏāĻāĻā§āϤ āĻĻāĻŋāĻā§āĻā§āĨ¤
# # # 8. āĻĢā§ā§āĻžāϰ āĻā§āϝāĻžāϞ⧠āĻ
āύā§āĻŽāĻžāύ
| āĻĢā§ā§āĻžāϰ āĻā§āϝāĻžāϞ⧠| 10 BDT |
|----------------|--------|
**āĻŦāĻŋāĻļā§āϞā§āώāĻŖ**: āĻā§āĻŽā§āĻĒāĻžāύāĻŋāϰ āĻāĻŦāĻŋāώā§āϝāϤā§āϰ āĻāĻžā§āĻāĻžāϰ āĻāύā§āϝ āĻāĻ āĻĢā§ā§āĻžāϰ āĻā§āϝāĻžāϞ⧠āĻāĻĒāϝā§āĻā§āϤ āĻŽāύ⧠āĻšāĻā§āĻā§āĨ¤
# # # 9. āĻā§āϰāϝāĻŧ, āĻŦāĻŋāĻā§āϰāϝāĻŧ, āĻāĻŦāĻ āĻŦāĻžāĻŖāĻŋāĻā§āϝ āϏā§āĻĒāĻžāϰāĻŋāĻļ
| āĻĒā§āϰāĻŦā§āĻļ āĻŽā§āϞā§āϝ | āϏā§āĻāĻĒ-āϞāϏ | 1āĻŽ āĻā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ | 2āϝāĻŧ āĻā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ |
|-------------|---------|----------------|----------------|
| 9.9 BDT | 8.8 BDT | 10.5 BDT | 11.5 BDT |
# # # 10. āĻā§āĻāĻāĻŋ āĻŦā§āϝāĻŦāϏā§āĻĨāĻžāĻĒāύāĻž
**āĻā§āĻāĻāĻŋ āĻā§āĻŦāĻŋāϞ**: 2%/5% āĻā§āĻāĻāĻŋ āĻāĻĻāĻžāĻšāϰāĻŖ āĻĻā§āĻāϝāĻŧāĻž āĻšāϝāĻŧā§āĻā§āĨ¤
---
# # # āĻĒāϰāĻžāĻŽāϰā§āĻļ
āĻĻā§āϰāώā§āĻāĻŦā§āϝ: āĻĒā§āϰāĻĨāĻŽ āϧāĻžāĻĒā§ āĻāĻāĻļāĻŋāĻ āĻŽā§āύāĻžāĻĢāĻž āϤā§āϞā§āύ, āĻĒāϰā§āϰ āϧāĻžāĻĒā§ āĻŦāĻžāĻāĻŋ āĻļā§āϝāĻŧāĻžāϰ āĻŦāĻŋāĻā§āϰāĻŋ āĻāϰ⧠āĻŽā§āύāĻžāĻĢāĻž āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰā§āύāĨ¤
# # # āĻŦāĻŋāĻĻāĻžā§ āĻŽāύā§āϤāĻŦā§āϝ
āĻāĻāύ āĻĒāϰā§āϝāύā§āϤ āϤāĻĨā§āϝ āĻ
āύā§āϝāĻžāϝāĻŧā§, āĻāĻĒāύāĻŋ āϏāĻŋāϞāĻāĻž āĻĢāĻžāϰā§āĻŽāĻžāϏāĻŋāĻāĻāĻŋāĻā§āϝāĻžāϞāϏ āĻāĻŋāύāϤ⧠āĻĒāĻžāϰā§āύāĨ¤ **āϝāĻĻāĻŋ āĻĻāĻžāĻŽ 9.8 āĻāĻžāĻāĻžāϰ āύāĻŋāĻā§ āĻāϞ⧠āϝāĻžāϝāĻŧ, āϤāĻŦā§ āĻŦāĻŋāĻā§āϰāĻŋ āĻāϰāĻžāϰ āĻāύā§āϝ āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰā§āύāĨ¤**